RxDoctor Payments Data

Rajwardhan Yadav

Rheumatology · Southington, CTNPI 1134445653

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.3% of the total across 298 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 21.9% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $3,417, more than ten times the $12 reported in 2021.

$5,893in general payments, 2019–2025

Across 298 payments — averaging $19.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Amgen$787
  • Johnson & Johnson$688
  • Mallinckrodt Hospital Products Inc.$676
  • UCB, Inc.$499
  • AstraZeneca$437
  • plus $2K from 18 others

What the payments were for

  • Food & beverage$5,73397%
  • Education$1603%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,893 in reported general payments places this provider in the 75th percentile of 118 rheumatology providers in Connecticut.

See all rheumatology providers in Connecticut

Medicare billing

Part B allowed, 2024
$19,915
Medicare patients
61
Services billed
375

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Diclofenac Sodium27$1,529
Hydroxychloroquine Sulfate55$1,464
Febuxostat16$1,292
MethotrexateMethotrexate Sodium88$859
Azathioprine12$588
Prednisone170$529
Tramadol Hcl55$379
Gabapentin21$300
Folic Acid14$150
Cyclobenzaprine Hcl11$104
Allopurinol12$55
Trazodone Hcl18$45

Paid to pharmacies, not to this prescriber.

Other rheumatology in Southington

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →